SRTAStrata Critical Medical, Inc.
$4.46-13% 1Y
$4.46
$4.0352 weeks$6.47
The financials
Strata Critical Medical, Inc. by the numbers
Strata Critical Medical, Inc. (SRTA) reported revenue of $73M in Q2 2026 (quarter ended Jun 30, 2026), up 61% from the same quarter a year earlier. That came with a gross margin of 21% and net loss of $11M. For the full year FY2025, revenue was $197M (+34% year on year) and net income $41M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $73M | $45M | +61% |
| Gross profit | $15M | $9.0M | +69% |
| Operating income | −$5.4M | −$4.6M | n/a |
| Net income | −$11M | −$3.7M | n/a |
| Diluted EPS | −$0.12 | −$0.05 | n/a |
Medical Care Facilities
Ranks #27 of 27 by RyuScore